Liver transplantation for hepatocellular carcinoma in Singapore

Singapore Medical Journal

Volumn 47, Issue 7, 2006, Pages 584-587

  Wai, C T ^a   Lee, Y M ^a   Wang, S C ^b   Da Costa, M ^b   Isaac, J ^b   Wee, A ^b   Lim, Seng Gee ^a  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Chronic hepatitis B; Chronic hepatitis C; Cirrhosis; Hepatocellular carcinoma; Liver transplantation

Indexed keywords

ALPHA FETOPROTEIN;

CHEMOEMBOLIZATION; HUMAN; LEUKOCYTE COUNT; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; PROTEIN BLOOD LEVEL; PROTHROMBIN TIME; RADIOFREQUENCY ABLATION; REVIEW; SINGAPORE; SURGICAL MORTALITY; SURVIVAL RATE;

CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MIDDLE AGED; SINGAPORE; WAITING LISTS;

EID: 33745902826     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Bosch FX, Ribes J, Borras J. Epidemiology of primary liver cancer. Semin Liver Dis 1999; 19:271-85.
2. Seow A, Koh WP, Chia KS, et al. Trends in cancer incidence in Singapore 1968-2002. Singapore Cancer Registry Report No. 6.
3. Takayama Y, Sherman M. Screening and treatment for hepatocellular carcinoma. Gastroenterol Clin N Am 2004; 33:671-91.
4. Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL Conference. J Hepatol 2001; 35:421-30.
5. Nonami T, Nakao A, Kurokawa T, et al. Blood loss and ICG clearance as best prognostic markers of post-hepatectomy liver failure. Hepatogastroenterology 1999; 46:1669-72.
6. Arii S, Yamaoka Y, Futagawa S, et al. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology 2000; 32:1224-9.
7. Fong Y, Sun RL, Jarnagin W, et al. An analysis of 412 cases of hepatocellular carcinoma at a Western centre. Ann Surg 1999; 229:790-9.
8. Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999; 30:1434-40.
9. Yao FY, Bass NM, Ascher NL, et al. Liver transplantation for hepatocellular carcinoma: lessons from the first year under the Model of End-Stage Liver Disease (MELD) organ allocation policy. Liver TranspI2004; 10:621-30.
10. Yao FY, Bass NM, Nikolai B, et al. Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list. Liver Transpl 2002; 8:873-83.
11. Bismuth H, Majno PE, Adam R. Liver transplantation for hepatocellular carcinoma. Semin Liver Dis 1999; 19:311-22.
12. Wai CT, Lo SK, Lee KH, et al. 10 years of experience of liver transplantation in Singapore. Transplant Proc 2000; 32:2139.
13. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334:693-9.
14. Ho MC, Wu YM, Hu RH, et al. Liver transplantation for patients with hepatocellular carcinoma. Transplant Proc 2004; 36:2291-2.
15. Bhattacharjya S, Bhattacharjya T, Quaglia A, et al. Liver transplantation in cirrhotic patients with small hepatocellular carcinoma: an analysis of pre-operative imaging, explant histology and prognostic histologic indicators. Dig Surg 2004; 21:152-9.
16. Klintmalm GB. Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome. Ann Surg 1998; 228:479-90.
17. Varela M, Sala M, Llovet JM, Bruix J. Review article: natural history and prognostic prediction of patients with hepatocellular carcinoma. Aliment Pharmacol Ther 2003; 17 Suppl 2:98-102.
18. Bruix J, Sala M, Llovet JM. Chemoembolization for hepatocellular carcinoma. Gastroenterology 2004; 127(5 Suppl 1):S179-K8.